Table 1.
Subject demographics.
| SCI patients (n = 18) Mean ± SD | Healthy controls (n = 22) Mean ± SD | Statistic value | P-value | |
|---|---|---|---|---|
| Gender(male/female) | 7/11 | 8/14 | χ2 = 0.027 | 0.870 |
| Age (years) | 42.33 ± 16.65 | 37.18 ± 12.24 | t = 1.097 | 0.279 |
| Illness duration (months) | 2.39 ± 1.53 | – | – | – |
| AISA level | C(4), D(14) | – | – | – |
| Mean motion (first session, mm) | 0.058± 0.038 | 0.038 ±0.033 | t = 1.699 | 0.098 |
| Mean motion (second session, mm) | 0.050 ± 0.032 | – | t = 1.006 | 0.330* |
| Lower limb movement (before) | 32.56 ± 8.36 | – | t = 6.253 | <0.001* |
| Lower limb movement (after) | 37.06 ± 7.74 | - | Wilcoxon stat = 0 | <0.001* |
| Sensory (before) | 161.44 ± 32.45 | – | t = 1.982 | 0.064* |
| Sensory (after) | 163.00 ± 32.81 | – | Wilcoxon stat = 0 | 0.042* |
| SCIM (before) | 52.72 ± 15.77 | – | t = 3.884 | 0.001* |
| SCIM (after) | 59.00 ± 16.71 | – | Wilcoxon stat = 0 | <0.001* |
For clinical measurements, lower limb movement and sensory and SCIM scores before and after treatment were shown. Significant results were shown in bold (P < 0.05).
*
Paired tests were performed on the first (before) and second (after) session (treatment) data.